Results for this period
First quarter1 January 2026–31 March 2026ConsolidatedIFRSThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Stacked from zero: upward is an increase in cash, downward a decrease (in ¥ thousand).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.
Research and development expenses increased by ¥68 million year on year, mainly due to higher development costs for emixustat hydrochloride and Kubota Glass®. The primary reason for negative operating cash flow was an increase in payments for research and development expenses.
Significant events, etc. disclosed. The company recognizes a situation in which the continuation of operating losses and negative operating cash flow raises significant doubt about the going concern assumption. However, it has determined that sufficient funds have been secured for the foreseeable development of the business and that no material uncertainty exists.
| Item | Details |
|---|---|
| Fiscal Period Classification | First quarter |
| Accounting standards | IFRS |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 January 2026–31 March 2026 |
| Net Sales | ¥5 million (YoY -35.2%) |
| Operating profit | ¥-313 million |
| Ordinary income | ¥-312 million |
| Profit attributable to owners of the parent | ¥-312 million |
| Net income per share | −¥2.58 |
| Equity ratio | End of the current fiscal period 89.9 % / End of previous period 91.6 % |
| Total assets | ¥1,864 million |
| Net assets | ¥1,676 million |
| Cash flows from operating activities | ¥-281,962 thousand |
| Cash flows from investing activities | ¥-9,219 thousand |
| Cash flows from financing activities | ¥158,231 thousand |
| Cash and cash equivalents at end of period | ¥1,787,964 thousand |
| Annual Dividend Forecast | ¥0 → ¥0（0.0%） |
| Impairment loss | ¥11,017 thousand |
| Disclosure regarding the going concern assumption | Significant events, etc. disclosed. The company recognizes a situation in which the continuation of operating losses and negative operating cash flow raises significant doubt about the going concern assumption. However, it has determined that sufficient funds have been secured for the foreseeable development of the business and that no material uncertainty exists. |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement Not disclosed |
| Changes in the scope of consolidation | New 0 companies / Excluded 0 companies / Company name None |
| Material subsequent events | The disclosure covers a reduction in stated capital and the appropriation of other capital surplus, the grant of stock options, and the issuance of 1,740,000 new shares as restricted stock compensation. |
| Availability of Supplementary Financial Results Materials | No |
| Availability of Financial Results Briefing | No |
| Issued Shares at Period-End | 138,504,288 shares |
| Treasury Shares at Period-End | 187 shares |
| Factors Behind Changes in Business Performance | Research and development expenses increased by ¥68 million year on year, mainly due to higher development costs for emixustat hydrochloride and Kubota Glass®. The primary reason for negative operating cash flow was an increase in payments for research and development expenses. |
Items this document does not state (11)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Research and development expenses increased by ¥68 million year on year, mainly due to higher development costs for emixustat hydrochloride and the myopia-progression management device Kubota Glass®. The company did not explain the direct reasons for the decline in business revenue.